Skip to main content
. 2018 Apr 20;2(2):pky004. doi: 10.1093/jncics/pky004

Table 1.

Characteristics of sample population

Cancer survivor (n = 1603)
No history of cancer(n = 34 915)
No. (weighted %) No. (weighted %) Chi-square P
Age, y
 18–34 192 (10.6) 13 513 (38.2) <.01
 35–44 241 (14.3) 7772 (21.4) <.01
 45–54 457 (27.8) 7796 (22.6) <.01
 55–64 713 (47.3) 5834 (17.8) <.01
Sex
 Male 482 (34.1) 1 612 (50.2) <.01
 Female 1121 (65.9) 18 303 (49.8) <.01
Race/ethnicity
 White, non-Hispanic 1055 (80.6) 15 153 (64.4) <.01
 Black, Hispanic, other 548 (19.4) 19 762 (35.6) <.01
Marital status
 Married 882 (59.5) 17 759 (52.5) <.01
 Not married 721 (40.5) 17 156 (47.5) <.01
Education*
 Less than high school 280 (11.9) 8492 (17.2) <.01
 High school grad/college 1319 (88.1) 26 264 (82.8) <.01
Family size
 Single 292 (20.2) 4847 (17.1) <.01
 Dyad 579 (38.9) 7956 (26.6) <.01
 3+ 732 (40.9) 22 112 (56.2) <.01
Family income, % FPL
 <399 1017 (53.5) 24 293 (59.1) <.01
 400+ 586 (46.5) 10 604 (40.9) <.01
Employment status
 Employed 956 (64.2) 25 165 (76.1) <.01
 Retired/not employed/other 647 (35.8) 9750 (23.9) <.01
Health insurance
 Private 1029 (73.8) 21 266 (70.7) <.01
 Public only 357 (15.7) 5155 (10.5) <.01
 Uninsured 217 (10.5) 8494 (18.8) <.01
No. of comorbid conditions
 0 409 (25.9) 18 743 (52.6) <.01
 1 364 (24.2) 7946 (23.5) .96
 2+ 830 (49.9) 8226 (23.9) <.01
Year
 2008 343 (20.6) 7030 (20.9) .22
 2009 466 (29.2) 10 360 (27.9) .61
 2010 427 (27) 9276 (27.7) .95
 2011 367 (23.2) 8249 (23.4) .5
Years since first cancer diagnosis
 ≤1 206 (13.1) N/A
 2–5 459 (28.8)
 6–9 267 (16.1)
 10–19 358 (22.7)
 ≥20 213 (14)
 Missing 100 (5.3)
In treatment†
 Yes 274 (18.2)
 No 1329 (81.8)
*

Out of 1603 cancer survivors, four had missing values for educational attainment. Out of 34 915 individuals without a history of cancer, 159 had missing values. FPL = federal poverty level.

In treatment was defined as receiving chemotherapy or radiation therapy for a cancer condition in either an outpatient or office-based setting or having a prescription for an antineoplastic medication.